Intervention not reported
Mortality · patients undergoing abdominal or pelvic surgery
The intervention showed no clear difference in mortality (moderate certainty).
1 finding from 1 review
Intervention not reported
Mortality prior to hospital discharge · very preterm (< 32 weeks' gestation) or very low birth weight (< 1500 g) infants
The intervention showed no clear difference in mortality prior to hospital discharge (low certainty).
1 finding from 1 review
All‐cause mortality: range 1 mo to 1 y · adults admitted to the ICU
It is very uncertain whether higher changes all‐cause mortality: range 1 mo to 1 y compared with lower FiO2 or targets of arterial oxygenation (very low certainty).
1 finding from 1 review
All‐cause short‐term mortality: 1 month · adults with low cardiac output syndrome
It is very uncertain whether enoximone changes all‐cause short‐term mortality: 1 month compared with dobutamine (very low certainty).
1 finding from 1 review
All‐cause short‐term mortality: 1 month · adults with cardiogenic shock or low cardiac output syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality during hospital stay · preterm or very low birth weight infants
It is very uncertain whether summary of findings table ‐ Silicone earplugs changes all‐cause mortality during hospital stay compared with no earplugs (very low certainty).
1 finding from 1 review
Mortality at 12 months post‐hip fracture · adults with dementia following hip fracture surgery
It is very uncertain whether interdisciplinary enhanced rehabilitation (inpatient and community… changes mortality at 12 months post‐hip fracture compared with conventional rehabilitation (very low certainty).
1 finding from 1 review
All cause mortality (timing not specified) · people undergoing major amputation of the lower extremity
1 finding from 1 review
All‐cause mortality within 30 days of surgery · people with a low platelet count
It is very uncertain whether prophylactic platelet transfusion prior to surgery changes all‐cause mortality within 30 days of surgery compared with no prophylactic platelet transfusion prior to surgery (very low certainty).
1 finding from 1 review
Intervention not reported
Died Mortality rate per 10,000 child‐months ( · children and adults in low‐ and middle‐income countries
It is very uncertain whether the intervention changes died Mortality rate per 10,000 child‐months ( (very low certainty).
1 finding from 1 review
Intervention not reported
Died Mortality rate per 10,000 child‐months ( · children and adults in low‐ and middle‐income countries
It is very uncertain whether the intervention changes died Mortality rate per 10,000 child‐months ( (very low certainty).
1 finding from 1 review
Mortality before hospital discharge · very preterm or very low birth weight infants
1 finding from 1 review
Mortality before hospital discharge · extremely preterm or extremely low birth weight infants
1 finding from 1 review
Mortality before hospital discharge · very preterm or very low birth weight infants
1 finding from 1 review
Mortality before hospital discharge · very preterm or very low birth weight infants
1 finding from 1 review
Mortality before hospital discharge · exclusively formula‐fed preterm or low birth weight infants
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause short‐term mortality: time in hospital · adults with low cardiac output syndrome
It is very uncertain whether dopexamine changes all‐cause short‐term mortality: time in hospital compared with dopamine (very low certainty).
1 finding from 1 review
All‐cause Mortality events in TKR combined doses · patients with prevention of venous thromboembolism following total hip or knee replacement
Direct thrombin inhibitors showed no clear difference in all‐cause Mortality events in TKR combined doses compared with vitamin K antagonists (low certainty).
1 finding from 1 review
All‐cause long‐term mortality: range 4 to 6 months · adults with cardiogenic shock or low cardiac output syndrome
It is very uncertain whether levosimendan changes all‐cause long‐term mortality: range 4 to 6 months compared with placebo (very low certainty).
1 finding from 1 review
Intervention not reported
Mortality during initial hospital stay (all causes) · preterm infants with low birth weight
The intervention showed no clear difference in mortality during initial hospital stay (all causes) (moderate certainty).
1 finding from 1 review